Bright Minds Biosciences, Inc. (DRUG.CX)
112.72
+4.46
(+4.12%)
CAD |
CNSX |
Dec 10, 12:28
Bright Minds Biosciences Shareholders Equity (Quarterly): 51.83M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| 4Front Ventures Corp. | -65.60M |
| Green Thumb Industries, Inc. | 2.544B |
| Lowell Farms, Inc. | 5.681M |
| Vireo Growth, Inc. | 342.71M |
| Wesana Health Holdings, Inc. | -0.8151M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 52.50M |
| Total Liabilities (Quarterly) | 0.6678M |
| Debt to Equity Ratio | 0.0027 |
| Current Ratio | 86.56 |
| Net Debt Paydown Yield | -0.01% |